Mumbai, Aug. 5 -- The company's consolidated net profit jumped 115.19% year-on-year to Rs 100.88 crore in Q1 FY27 from Rs 46.88 crore in the corresponding quarter last year.

Revenue from operations increased 44.89% YoY to Rs 465.78 crore, reflecting broad-based growth across its API, formulations and biologics businesses.

Profit before tax (PBT) rose 97.78% YoY to Rs 98.06 crore during the quarter.

Operating performance remained strong, with EBITDA increasing 42% YoY to Rs 139 crore from Rs 98 crore in Q1 FY26. EBITDA margin remained steady at 30%, indicating sustained operating efficiency despite the sharp rise in revenue.

On the business front, the API segment contributed 47% of total revenue, followed by the formulations business a...